Articles related to MOVEMENT DISORDERS

Effective management of tardive dyskinesia requires early prevention with second-generation antipsychotics and the use of VMAT2 inhibitors like deutetrabenazine and valbenazine, which offer the highest quality evidence for reducing symptoms.

Non-invasive digital health tools, including wearable sensors and tremor-suppressing devices, are emerging as valuable adjuncts to traditional treatments for tremor management, significantly enhancing patient autonomy and quality of life.

Recent findings from UC Davis highlight the role of executive function challenges as early indicators in men with FMR1 premutations for developing fragile X-associated tremor/ataxia syndrome (FXTAS), presenting a new avenue for timely intervention.

Stiff-person syndrome, a rare yet impactful neurological disorder, presents a unique intersection with various autoimmune diseases. Understanding its symptoms and treatment strategies is crucial for patient care.

Uncover the often-overlooked complication of diabetes, diabetic cheiroarthropathy, and its potential links to microvascular complications.

The recent findings on valbenazine’s fast onset of action in treating chorea associated with HD could be a game-changer for the 30,000 Americans living with this disease.